StockData
Dermata Therapeutics, Inc. logo

Dermata Therapeutics, Inc. (DRMA) stock

DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.57−0.03 (-4.75%)

Close on Nov 17, 2026Market cap $2.29MP/E –Yield –

Dermata Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Dermata Therapeutics's price to book ratio was 0.8× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 360.1×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×+0.3
2025Dec 31, 20250.5×+0.0
2024Dec 31, 20240.5×−4.1
2023Dec 29, 20234.6×−154.5
2022Dec 30, 2022159.0×−119.4
2021Dec 31, 2021278.4×–

More Dermata Therapeutics figures

See a number that looks wrong?